Target intelligence / Profile preview

Immune system modulation via repeated exposure to allergen

Molecular classification
Other (not a single molecule, receptor, or protein)
01

Overview

Immune system modulation via repeated exposure to allergen" refers to the process underlying **allergen-specific immunotherapy** or **desensitization**, where controlled and repeated administration of an allergen leads to changes in the immune response. This is not a single molecular entity but rather describes an overall therapeutic approach that aims to induce immune tolerance. The mechanism involves several key steps: • Initial sensitization occurs when antigen-presenting cells present allergens on MHCII molecules to T cells. This leads to differentiation into Th2 helper cells under the influence of interleukins such as IL‑4. Th2 cells then stimulate B cell-derived plasma cells to produce IgE antibodies specific for the allergen. • Upon re-exposure, these IgE antibodies bind high-affinity FcεRI receptors on mast cells and basophils. Crosslinking triggers degranulation and release of inflammatory mediators like histamine, prostaglandins, leukotrienes, causing allergic symptoms[1][3]. • Repeated controlled exposure through immunotherapy can shift this response toward increased regulatory T cell activity—especially Foxp3+ Tregs—which suppress effector T cell responses through secretion of anti-inflammatory cytokines such as IL‑10 and TGF‑β[2]. This reduces Th2-driven inflammation and promotes long-term tolerance. • The process also involves changes in antibody class switching from IgE toward non-inflammatory isotypes like IgG4. This concept does not refer to any one protein/receptor/enzyme/transporter but rather encompasses multiple cellular pathways involved in allergy development and resolution. Therefore it should not be considered a canonical therapeutic target at the molecular level. If you require structured information about individual molecules involved—such as FcεRI receptor or regulatory T cell markers—please specify those targets individually.

Other names
Allergen-specific immunotherapyAllergen desensitizationImmune tolerance induction (via allergen)Allergen exposure therapy
02

Biological functions

Immune responseInduction of immune toleranceModulation of hypersensitivity reactionsSuppression of pro-inflammatory cytokines[2]
03

Disease associations

AllergyInflammation[1][2]Other (immune-mediated diseases)
04

Safety considerations

Risk of anaphylaxisOther allergic reactions
05

Biomarkers

Regulatory T cell activityIgE levelsCytokine profiles

Beyond the preview

Go deeper on Immune system modulation via repeated exposure to allergen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system modulation via repeated exposure to allergen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call